TELEPHONE: +1 (503) 894-6022 E-MAIL: sales@researchbeam.com
Report Overview ‘Glucagon-Like Peptide 2 Receptor (GLP-2 Receptor or GLP2R) - Pipeline Review, H1 2016’, provides in depth analysis on Glucagon-Like Peptide 2 Receptor (GLP-2 Receptor or GLP2R) targeted pipeline therapeutics. The report provides comprehensive information on the Glucagon-Like Peptide 2 Receptor (GLP-2 Receptor or GLP2R), targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Glucagon-Like Peptide 2 Receptor (GLP-2 Receptor or GLP2R) targeted therapeutics development and features dormant and discontinued projects.
Scope - The report provides a snapshot of the global therapeutic landscape for Glucagon-Like Peptide 2 Receptor (GLP-2 Receptor or GLP2R)
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities Read More At: http://www.researchbeam.com/glucagon-like-peptide-2-receptor-glp-2-receptor-orglp2r-pipeline-review-h1-2016-market
Report Overview Reasons to buy Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counterstrategies to gain competitive advantage Identify and understand the targeted therapy areas and indications for Glucagon-Like Peptide 2 Receptor (GLP-2 Receptor or GLP2R) Identify potential new clients or partners in the target demographic Develop strategic initiatives by understanding the focus areas of leading companies
Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Glucagon-Like Peptide 2 Receptor (GLP-2 Receptor or GLP2R) development landscape Read More At: http://www.researchbeam.com/glucagon-like-peptide-2-receptor-glp-2-receptor-orglp2r-pipeline-review-h1-2016-market
List of Tables Number of Products under Development for, H1 2016 7 Number of Products under Development by Therapy Area, H1 2016 8 Number of Products under Development by Indication, H1 2016 9 Comparative Analysis by Late Stage Development, H1 2016 10 Comparative Analysis by Early Stage Products, H1 2016 11 Number of Products under Development by Companies, H1 2016 12 Products under Development by Companies, H1 2016 13 Assessment by Monotherapy/Combination Products, H1 2016 14 Number of Products by Stage and Mechanism of Action, H1 2016 15 Number of Products by Stage and Route of Administration, H1 2016 16 Number of Products by Stage and Molecule Type, H1 2016 18 Pipeline by Naia Limited, H1 2016 19 Pipeline by Shire Plc, H1 2016 20 Pipeline by Tasly Pharmaceutical Group Co., Ltd., H1 2016 21 Pipeline by Zealand Pharma A/S, H1 2016 22 Dormant Projects, H1 2016 35
Enquire At : http://www.researchbeam.com/glucagon-like-peptide-2-receptor-glp-2-receptor-or-glp2rpipeline-review-h1-2016-market/enquire-about-report
FOR MORE DETAILS Visit us at : http://www.researchbeam.com/glucagon-like-peptide-2-receptor-glp-2-receptor-orglp2r-pipeline-review-h1-2016-market
Stay With Us:
TELEPHONE: +1 (800) 910-6452 DIRECT: +1 (503) 894-6022 E-MAIL: sales@researchbeam.com
5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States